Join us on Tuesday 23 September, 9am to 4:30pm, for an exciting event exploring the innovations for blood pressure detection and monitoring.
We are all aware of the 10 Year Plan for England and its three shifts:
- hospital to community
- analogue to digital
- sickness to prevention.
This event is demonstrating how these can be achieved for blood pressure management and impact cardiovascular disease risk and outcomes for patients. Technology and innovation are key for the aim of wearables and biosensors being standard in prevention, chronic and post-acute NHS treatment. The introduction of neighbourhood health centres will see the shift of care closer to home. This is your opportunity to see and hear about innovations that can support this for hypertension management.
Monitoring blood pressure is key across all aspects of the UK health system:
- high blood pressure is the leading modifiable risk factor for heart and circulatory disease in the UK
- an estimated 30% of adults in the UK have high blood pressure – that’s around 16 million, up to half of them are not receiving effective treatment
- heart and circulatory diseases cause around a quarter of all deaths in the UK; that's more than 170,000 deaths a year, 480 each day – one every three minutes
- around 50 per cent of heart attacks and strokes are associated with high blood pressure in the UK.
(UK Factsheet, British Heart Foundation, Jan 2025)
You will have opportunity to hear from, and see, some of the leading innovations in this clinical space. Learn about the positive impacts these are having on patient outcomes, clinical workflows and economic returns in both primary and secondary care.
Keynote speakers include:
- Helen Williams, National Clinical Director for CVD Prevention, NHS England
- Alec Price-Forbes, National Chief Clinical Information Officer, Transformation Directorate, NHS England
- Dr Fozia Ahmed, Consultant cardiologist, Manchester University NHS Foundation Trust
- Paul Stevens, Global Director Data Service Business, Digital Health HQ OMRON
- Dr Matt Kearney, Founder CVDACTION, CVDPREVENT and the Proactive Care Frameworks, Senior Advisor to UCL Partners and former National Clinical Director for CVD Prevention England
- Geraint Lewis, Director of Population Health, Microsoft.
Featured innovations include:
- Lifelight – world first smartphone app, that requires no additional hardware, with class IIa classification for blood pressure measurement
More to be announced soon.
Our event aims to bring together those working clinically and commissioners, to instigate discussion and action to reduce the risk and improve the outcomes.
Register now and don’t miss your opportunity to be part of the future.
We do ask for a £20 deposit on registration to secure a ticket, refunded on attendance.
For any enquiries, please email innovation@hiwessex.net
This event is appropriate for those who:
- work in primary care and see and manage patients with blood pressure or CVD-related illnesses
- work in secondary care in hypertension or CVD-related specialities
- complete regular vital signs monitoring of patients either in primary, secondary or community care
- commission health or care services
- work in transformation departments
